retatrutide trial weight loss just delivered the first top-line Phase 3 results for a triple agonist in obesity โ and the findings from TRIUMPH-4 are striking๐ The numbers from Lilly's Phase
Description
Dietary patterns and growth, size, body composition, and/or risk of overweight or obesity: a systematic review
Papamargaritis D, le Roux CW
10.3390/ijms252212465 [DOI] [PMC free article] [PubMed] [Google Scholar] 41.Henning RJ, Sawmiller DR
This is particularly important when one of the components has a narrow therapeutic window
At three meals per day, that's 2033g per meal minimum
Rapid weight loss raises gallstone risk
